We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$56.6B
AUM Growth
-$4.33B
(-7.1%)
Cap. Flow
-$5.51B
Cap. Flow
% of AUM
-9.73%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
1,739
New
42
Increased
177
Reduced
1,384
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$201M |
| 2 |
Oracle
ORCL
|
+$135M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$123M |
| 4 |
Invesco MSCI USA ETF
PBUS
|
+$80.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$267M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 3 |
NVIDIA
NVDA
|
+$172M |
| 4 |
JPMorgan Chase
JPM
|
+$137M |
| 5 |
Apple
AAPL
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.12% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 12.38% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
C3.ai
AI
$1.38B
| $164K | ﹤0.01% |
12,195
-18,650
| -60% | -$298K |
|
|
CNH
1402
CNH Industrial
CNH
$14.2B
| $164K | ﹤0.01% |
17,800
-11,050
| -38% | -$110K |
|
1403
CVB Financial
CVBF
$4.02B
| $164K | ﹤0.01% |
8,793
-16,900
| -66% | -$323K |
|
1404
Cactus
WHD
$3.69B
| $163K | ﹤0.01% |
3,579
-7,200
| -67% | -$301K |
|
1405
Strategic Education
STRA
$1.84B
| $163K | ﹤0.01% |
2,038
-3,450
| -63% | -$275K |
|
1406
Four Corners Property Trust
FCPT
$2.85B
| $163K | ﹤0.01% |
7,081
-15,050
| -68% | -$358K |
|
1407
Trustmark
TRMK
$2.74B
| $163K | ﹤0.01% |
4,190
-6,650
| -61% | -$259K |
|
|
CON
1408
Concentra Group Holdings
CON
$4.18B
| $163K | ﹤0.01% |
8,282
-21,300
| -72% | -$426K |
|
1409
Patterson-UTI
PTEN
$3.48B
| $163K | ﹤0.01% |
26,645
-69,400
| -72% | -$414K |
|
1410
AtriCure
ATRC
$2.01B
| $163K | ﹤0.01% |
4,115
-13,000
| -76% | -$477K |
|
1411
Ziff Davis
ZD
$1.95B
| $163K | ﹤0.01% |
4,627
-9,300
| -67% | -$324K |
|
1412
TripAdvisor
TRIP
$1.74B
| $163K | ﹤0.01% |
11,165
-21,600
| -66% | -$329K |
|
1413
Horace Mann Educators
HMN
$2.12B
| $162K | ﹤0.01% |
3,500
-6,000
| -63% | -$272K |
|
1414
Herbalife
HLF
$1.3B
| $161K | ﹤0.01% |
+12,500
| New | +$132K |
|
1415
Aurinia Pharmaceuticals
AUPH
$1.92B
| $161K | ﹤0.01% |
10,085
-22,750
| -69% | -$322K |
|
1416
Progress Software
PRGS
$1.66B
| $161K | ﹤0.01% |
3,744
-6,300
| -63% | -$275K |
|
1417
Evertec
EVTC
$1.94B
| $159K | ﹤0.01% |
5,460
-13,300
| -71% | -$395K |
|
1418
Axcelis
ACLS
$3.69B
| $158K | ﹤0.01% |
1,966
-4,300
| -69% | -$360K |
|
1419
FIVE9
FIVN
$2.08B
| $157K | ﹤0.01% |
7,835
-15,600
| -67% | -$331K |
|
1420
Dentsply Sirona
XRAY
$2.7B
| $157K | ﹤0.01% |
13,739
-36,200
| -72% | -$425K |
|
1421
ABM Industries
ABM
$2.88B
| $157K | ﹤0.01% |
3,707
-10,600
| -74% | -$466K |
|
1422
Digi International
DGII
$2.53B
| $157K | ﹤0.01% |
3,620
-5,350
| -60% | -$214K |
|
1423
Qiagen
QGEN
$8.72B
| $157K | ﹤0.01% |
3,433
| – | – |
|
1424
Ingevity
NGVT
$2.59B
| $156K | ﹤0.01% |
2,644
-6,450
| -71% | -$350K |
|
|
SLNO
1425
DELISTED
Soleno Therapeutics
SLNO
| $155K | ﹤0.01% |
3,351
-205,162
| -98% | -$11.2M |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Ensign Peak Advisors held 1,739 positions worth $56.6B, down 7.1% from $60.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ensign Peak Advisors withdrew a net $5.51B in Q4 2025, closing 54 positions and reducing 1,384 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in Invesco MSCI USA ETF worth $81.3M.
- Ensign Peak Advisors's largest Q4 2025 buy was Invesco MSCI USA ETF: 1,188,232 shares worth $81.3M.
- Ensign Peak Advisors added most to Eli Lilly in Q4 2025, an estimated $201M increase.
- Ensign Peak Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $267M.
- Ensign Peak Advisors fully exited iShares Core S&P 500 ETF in Q4 2025, selling an estimated $125M.
- Ensign Peak Advisors's ten largest holdings make up 37% of its $56.6B portfolio in Q4 2025.
- Ensign Peak Advisors opened 42 new positions and closed 54 in Q4 2025.
- Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $56.6B.
Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.